Sandra J Lobbestael

Title: **Sandra J. Lobbestael: A Pioneer in Anticonvulsant Innovations**

Introduction

Sandra J. Lobbestael is an accomplished inventor based in Dexter, Michigan. With a remarkable contribution in the field of pharmaceuticals, she holds two patents that demonstrate her innovative work in developing anticonvulsant compounds.

Latest Patents

Her latest patents focus on N-(2,6-disubstituted aromatic)-N'-pyridinyl ureas and N-(2,6-disubstitutedphenyl)-N'-3- and 4-pyridinyl ureas, as well as their pharmaceutically acceptable acid addition salts. These compounds exhibit significant anticonvulsant activity, along with a detailed process for their manufacture and formulations. Additionally, her inventions include a method for treating epilepsy using these compounds in unit dosage form.

Career Highlights

Sandra is associated with the Warner-Lambert Company, where she has furthered her research in pharmaceuticals and made strides in the development of new therapeutic agents. Her work not only highlights her expertise but also contributes to advancements in treatments for epilepsy.

Collaborations

During her career, she has collaborated with esteemed colleagues such as Ivan C. Nordin and Robert W. Fleming. These collaborations have likely fostered an environment of innovation and creativity, enhancing the potential impact of her patents in the medical field.

Conclusion

Sandra J. Lobbestael stands out as a significant figure in the area of anticonvulsant research. Her contributions, embodied in her patents and collaborative efforts, demonstrate a commitment to advancing medical science and improving therapeutic options for those affected by epilepsy.